Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05283148 · ClinicalTrials.gov registry record · NA

Sickle Cell Disease (SCD) Bone Pain Study

A NA study of Sickle Cell Disease and Osteoporosis, sponsored by University of California, Davis.

Active
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT05283148 is a NA study of Sickle Cell Disease and Osteoporosis that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 53 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05283148, a NA study of Sickle Cell Disease and Osteoporosis, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

A prospective study to determine how low bone mineral density and/or vertebral compression fractures associate with pain in adults with sickle cell disease

Interventions

  • OTHER Dual-energy X-ray absorptiometry
  • OTHER Vertebral fracture analysis
  • OTHER Adult Sickle Cell Quality of Life Measurement System pain impact questionnaire

Study Locations (1)

California

  • UC Davis Comprehensive Cancer Center - Sacramento

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2022-11-03
Est. Completion 2026-07-31
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT05283148

The ClinicalTrials.gov registry entry for NCT05283148 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (82% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 3 interventions - of which Dual-energy X-ray absorptiometry is the first listed.

NCT05283148 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05283148 about?

NCT05283148 is a clinical study titled "Sickle Cell Disease (SCD) Bone Pain Study". A prospective study to determine how low bone mineral density and/or vertebral compression fractures associate with pain in adults with sickle cell disease

What is the current status of trial NCT05283148?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 53 participants. The study started on 2022-11-03. Estimated completion is 2026-07-31.

What conditions does trial NCT05283148 study?

This clinical trial studies the following conditions: Sickle Cell Disease, Osteoporosis, Avascular Necrosis, Sickle Cell Anemia, Osteopenia.

What interventions are being tested in trial NCT05283148?

The interventions under investigation include: Dual-energy X-ray absorptiometry (OTHER), Vertebral fracture analysis (OTHER), Adult Sickle Cell Quality of Life Measurement System pain impact questionnaire (OTHER).

Who is sponsoring clinical trial NCT05283148?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05283148 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.